Beside P53 and PTEN: Identification of molecular alterations of the RAS/MAPK and PI3K/AKT signaling pathways in high-grade serous ovarian carcinomas to determine potential novel therapeutic targetsShuhui Chen, Alexandre Harlé|Oncology Letters|2016Cited by 20